Table 1 Clinical characteristics of human donors of muscle cells.
Controls | Type 2 diabetes | p-value | |
|---|---|---|---|
n | 14 | 14 | |
Gender (male/female) | 7/7 | 7/7 | |
Age | 54.2 ± 6.8 | 58.1 ± 6.6 | 0.14 |
Years of disease | 4.8 ± 4.0 | ||
Height (m) | 1.7 ± 0.1 | 1.7 ± 0.1 | 0.95 |
Weight (kg) | 74.5 ± 14.2 | 80.3 ± 13.4 | 0.28 |
BMI (kg/m2) | 24.7 ± 2.4 | 26.6 ± 3.1 | 0.07 |
Hip circumference (cm) | 100.6 ± 4.7 | 100.6 ± 8.7 | 1.00 |
Waist circumference (cm) | 85.9 ± 10.2 | 96.3 ± 8.7 | 0.01 |
Waist/hip ratio | 0.9 ± 0.1 | 1.0 ± 0.1 | 0.01 |
Body lean mass/BW (%) | 68.4 ± 8.7 | 64.4 ± 9.7 | 0.26 |
Body fat mass/BW (%) | 27.4 ± 8.4 | 31.1 ± 9.1 | 0.27 |
Android fat mass/BW (%) | 2.3 ± 0.7 | 3.2 ± 0.9 | 0.009 |
Gynoid fat mass/BW (%) | 5.6 ± 2.2 | 5.3 ± 2.0 | 0.74 |
Android/Gynoid fat ratio | 46.1 ± 18.0 | 65.3 ± 21.3 | 0.02 |
HbA1c (%)a | 5.5 ± 0.2 | 6.7 ± 1.1 | 0.002 |
Glucose 0 h (mmol/L) | 4.8 ± 0.6 | 9.1 ± 3.7 | 0.001 |
Glucose 2 h (mmol/L)b | 5.2 ± 1.3 | 18.2 ± 6.6 | 4.7 × 10−6 |
Insulin 0 h (pmol/L) | 32.1 ± 13.3 | 64.1 ± 41.9 | 0.02 |
Insulin 2 h (pmol/L)b | 230.1 ± 155.3 | 371.5 ± 298.9 | 0.13 |
HOMA-IR (%) | 1.0 ± 0.5 | 3.6 ± 2.3 | 0.001 |
HOMA-B (%) | 74.4 ± 26.7 | 44.2 ± 36.6 | 0.02 |
C-peptide 0 h (pmol/L) | 614.1 ± 144.4 | 817.6 ± 349.9 | 0.06 |
P-Cholesterol-total (mmol/L) | 5.5 ± 1.0 | 4.5 ± 0.7 | 0.01 |
P-Cholesterol-HDL (mmol/L) | 1.7 ± 0.5 | 1.3 ± 0.4 | 0.02 |
P-Cholesterol-LDL (mmol/L) | 3.3 ± 0.9 | 2.5 ± 0.7 | 0.02 |
Systolic blood pressure (mmHg) | 134.3 ± 12.0 | 140.8 ± 12.7 | 0.17 |
Diastolic blood pressure (mmHg) | 85.6 ± 9.5 | 90.8 ± 6.3 | 0.10 |
Pulse (beats/min) | 59.5 ± 12.4 | 68.6 ± 10.8 | 0.05 |
VO2 max (mL/min/kg) | 32.6 ± 11.4 | 26.4 ± 7.6 | 0.10 |